We are expanding the R&D team

1 October 2024

We are pleased to have Ananya Singh on board as scientist in the R&D team and as Doctoral candidate, she is part of the ORGESTRA MSCA Joint Doctorate network.

We are confident that her capabilities will contribute to Mercurna’s mission: “To deliver life-changing medicines for patients with inflammatory diseases, based on the software of life: mRNA”.